nach oben

Erschienen in:

02.12.2019 | Editorial

FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases series 4: is taking out all of a mesh sling too extreme?

verfasst von: Emily B. Rosenfeld, Ladin A. Yurteri-Kaplan, Chris Maher, Tony Bazi, Kamil Svabik, Sara Houlihan, Cara L. Grimes

Erschienen in: International Urogynecology Journal | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

A 46-year-old P2 presented with mesh exposure after a mid-urethral sling (MUS) procedure. She had a history of prolapse and mixed urinary incontinence and underwent a robotic-assisted total laparoscopic hysterectomy, bilateral salpingectomy, uterosacral colposuspension and MUS (Solyx Single-Incision Sling, Boston Scientific, USA). Six months after surgery, per patient, she was found to have vaginal granulation tissue that was excised in the operating room. Three months after that, she presented to her initial surgeon with dyspareunia and hispareunia. She tried a 12-week course of vaginal estrogen without resolution. Upon presentation, she complained of persistent mesh exposure, palpable to her and her husband, causing dyspareunia. On examination, no mesh could be visualized or felt, but palpation along a portion of the left sling arm revealed tenderness and thin overlying epithelium. No recurrent prolapse was noted. The patient strongly desires complete removal of the mesh, stating her reason for removal was “it is mesh.” …

Cundiff G, Quinlan D, Rensburg JV, Slack M. Foundation for an evidence-informed algorithm for treating pelvic floor mesh complications: a review. BJOG-Int J Obstet Gy. 2018;125:1026–37. https://doi.org/10.1111/1471-0528.15148.CrossRef

Devakumar H, Chandrasekaran N, Alas A, et al. Resolution of rectal prolapse by vaginal reconstruction. Female Pelvic Med Reconstr Surg. 2017;23:e4–7. https://doi.org/10.1097/spv.0000000000000354.CrossRefPubMed

Dray E, Crosby E, Grable A, et al. A retrospective analysis of surgical outcomes and risk factors for persistent postoperative symptoms following synthetic mid urethral sling revision. J Urol. 2019;202:339–46. https://doi.org/10.1097/ju.0000000000000246.CrossRefPubMed

Feiner B, Maher C. Vaginal mesh contraction: definition, clinical presentation, and management. Obstet Gynecol. 2010;115:325–30. https://doi.org/10.1097/aog.0b013e3181cbca4d.CrossRefPubMed

Ramart P, Ackerman AL, Cohen SA, et al. The risk of recurrent urinary incontinence requiring surgery after suburethral sling removal for mesh complications. Urology. 2017;106:203–9. https://doi.org/10.1016/j.urology.2017.01.060.CrossRefPubMed

Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.cd006375.pub4.

Hou JC, Alhalabi F, Lemack GE, Zimmern PE. Outcome of transvaginal mesh and tape removed for pain only. J Urol. 2014;192:856–60. https://doi.org/10.1016/j.juro.2014.04.006.CrossRefPubMed

Jonsson Funk M, Siddiqui NY, Pate V, et al. Sling revision/removal for mesh erosion and urinary retention: long-term risk and predictors. Am J Obstet Gynecol. 2013;208:73.e1–7. https://doi.org/10.1016/j.ajog.2012.10.006.CrossRef

Geller EJ, Babb E, Nackley AG, Zolnoun D. Incidence and risk factors for pelvic pain after mesh implant surgery for the treatment of pelvic floor disorders. J Minim Invas Gyn. 2017;24:67–73. https://doi.org/10.1016/j.jmig.2016.10.001.CrossRef

10.

Gurol-Urganci I, Geary RS, Mamza JB, et al. Long-term rate of mesh sling removal following midurethral mesh sling insertion among women with stress urinary incontinence. JAMA. 2018;320:1659. https://doi.org/10.1001/jama.2018.14997.CrossRefPubMedPubMedCentral

11.

Nygaard I, Barber MD, Burgio KL, Kentor K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. Pelvic Floor Disorders Network Jama. 2008;300:1311–6.PubMed

12.

Erekson EA, Lopes VV, Raker CA, Sung VW. Ambulatory procedures for female pelvic floor disorders in the United States. Am J Obstet Gynecol. 2010;203:497.e1–5. https://doi.org/10.1016/j.ajog.2010.06.055.CrossRef

13.

Center for Devices and Radiological Health. Considerations about surgical mesh for SUI. In: US Food and Drug Administration, 2019. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm. Accessed 27 Jul 2019.

14.

Barber M. Surgical treatment of stress urinary incontinence. In: Bent AE, Cundiff GW, Swift SE, editors. Ostergard's urogynecology and pelvic floor dysfunction. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 225–62.

15.

Jonsson Funk M, Siddiqui NY, Kawasaki A, Wu JM. Long-term outcomes after stress urinary incontinence surgery. Obstet Gynecol. 2012;120:83–90. https://doi.org/10.1097/aog.0b013e318258fbde.CrossRefPubMed

16.

Ward K, Hilton P. Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG-Int J Obstet Gy. 2007;115:226–33. https://doi.org/10.1111/j.1471-0528.2007.01548.x.CrossRef

17.

American College of Obstetricians and Gynecologists and the American Urogynecologic Society. ACOG practice bulletin no. 155: urinary incontinence in women. Obstet Gynecol. 2015;126:66–81. https://doi.org/10.1097/aog.0000000000001148.CrossRef

18.

Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J of Urol. 2017;198:875–83. https://doi.org/10.1016/j.juro.2017.06.061.CrossRef

19.

International Urogynecological Association. Position Statement on Mid-Urethral Slings for Stress Urinary Incontinence, 2018. https://www.iuga.org/files/48/Position-Statements/6/Position-Statement-on-Mid-Urethral-Slings-for-SUI.pdf. Accessed 27 Jul 2019.

20.

Royal Australian and New Zealand College of Obstetricians and Gynaecologists (2018) Position statement on midurethral slings. Position statement on midurethral slings. https://www.ranzcog.edu.au/Statements-Guidelines/Gynaecology/Midurethral-Slings,-Position-Statement-(C-Gyn-32). Accessed 27 Jul 2019.

21.

Nager C, Tulikangas P, Miller D, et al. Position statement on mesh midurethral slings for stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2014;20:123–5. https://doi.org/10.1097/spv.0000000000000097.CrossRefPubMed

22.

American College of Obstetricians and Gynecologists. Management of mesh and graft complications in gynecologic surgery. Committee opinion no. 694. Obstet Gynecol. 2017;129:102–8. https://doi.org/10.1097/aog.0000000000002022.CrossRef

23.

Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27:165–94. https://doi.org/10.1007/s00192-015-2932-1.CrossRefPubMed

24.

Brubaker L, Norton PA, Albo ME, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the trial of midurethral slings (TOMUS) study. Am J Obstet Gynecol. 2011;205:498.e1–6. https://doi.org/10.1016/j.ajog.2011.07.011.CrossRef

25.

Zullo MA, Plotti F, Calcagno M, et al. One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. Eur Urol. 2007;51:1376–84. https://doi.org/10.1016/j.eururo.2006.10.066.CrossRefPubMed

26.

Tseng LH, Wang AC, Lin YH, et al. Randomized comparison of the suprapubic arc sling procedure vs tension-free vaginal taping for stress incontinent women. Int Urogynecol J. 2004;16:230–5. https://doi.org/10.1007/s00192-004-1248-3.CrossRef

27.

Kokanali M, Doğanay M, Aksakal O, et al. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2014;177:146–50. https://doi.org/10.1016/j.ejogrb.2014.03.039.CrossRefPubMed

28.

El-Khawand D, Wehbe SA, O’Hare PG, et al. Risk factors for vaginal mesh exposure after mesh-augmented anterior repair. Female Pelvic Med Reconstr Surg. 2014;20:305–9. https://doi.org/10.1097/spv.0000000000000095.CrossRefPubMed

29.

Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362:2066–76. https://doi.org/10.1056/NEJMoa0912658.CrossRefPubMedPubMedCentral

30.

Abbott S, Unger CA, Evans JM, et al. Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study. Am J Obstet Gynecol. 2014;210:163.e1–8. https://doi.org/10.1016/j.ajog.2013.10.012.CrossRef

31.

Jambusaria LH, Heft J, Reynolds WS, et al. Incontinence rates after midurethral sling revision for vaginal exposure or pain. Am J Obstet Gynecol. 2016;215:–764.e1, 5. https://doi.org/10.1016/j.ajog.2016.07.031.CrossRef

32.

Duckett J, Bodner-Adler B, Rachaneni S, Latthe P. Management of complications arising from the use of mesh for stress urinary incontinence—International Urogynecology Association Research and Development Committee opinion. Int Urogynecol J. 2019. https://doi.org/10.1007/s00192-019-03935-8.CrossRef

Titel: FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases series 4: is taking out all of a mesh sling too extreme?
verfasst von: Emily B. Rosenfeld
Ladin A. Yurteri-Kaplan
Chris Maher
Tony Bazi
Kamil Svabik
Sara Houlihan
Cara L. Grimes
Publikationsdatum: 02.12.2019
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 2/2020
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-019-04172-9

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases series 4: is taking out all of a mesh sling too extreme?

Excerpt

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Vaginal hysterectomy with bilateral sacrospinous fixation plus an anterior mesh versus abdominal sacrocervicopexy for the treatment of primary apical prolapse in postmenopausal women: a randomized controlled study

Henry van Roonhuyse and the first repair of a vesico-vaginal fistula (~1676)

I leaked, then I Reddit: experiences and insight shared on urinary incontinence by Reddit users

De novo urinary incontinence after pelvic organ prolapse surgery—a national database study

Correction to: Patient attitudes toward pooled surgical waitlists in urogynecology

Factors in delay of diagnosis of gynecologic ureteral injuries at a rural academic hospital

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie